HomeInsightsStock Comparison

Ambalal Sarabhai Enterprises Ltd vs Ind Swift Ltd Stock Comparison

Ambalal Sarabhai Enterprises Ltd vs Ind Swift Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Ambalal Sarabhai Enterprises Ltd is ₹ 35.85 as of 16 Jul 14:59.
  • The P/E Ratio of Ambalal Sarabhai Enterprises Ltd changed from 10.4 on March 2020 to 54.8 on March 2025 . This represents a CAGR of 31.91% over 6 yearsThe P/E Ratio of Ind-Swift Ltd changed from 1.5 on March 2023 to 0 on March 2025 . This represents a CAGR of -100.00% over 3 years.
  • The Market Cap of Ambalal Sarabhai Enterprises Ltd changed from ₹ 145.99 crore on March 2020 to ₹ 268.6 crore on March 2025 . This represents a CAGR of 10.70% over 6 yearsThe Market Cap of Ind-Swift Ltd changed from ₹ 60.61 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 4 years.
  • The revenue of Ambalal Sarabhai Enterprises Ltd for the Mar '25 is ₹ 66.45 crore as compare to the Dec '24 revenue of ₹ 51.73 crore. This represent the growth of 28.46% The revenue of Ind-Swift Ltd for the Mar '25 is ₹ 426.19 crore as compare to the Dec '24 revenue of ₹ 122.96 crore. This represent the growth of 246.61%.
  • The ebitda of Ambalal Sarabhai Enterprises Ltd for the Mar '25 is ₹ -0.07 crore as compare to the Dec '24 ebitda of ₹ 5.06 crore. This represent the decline of -101% The ebitda of Ind-Swift Ltd for the Mar '25 is ₹ 278.4 crore as compare to the Dec '24 ebitda of ₹ 9.98 crore. This represent the growth of 2689%.
  • The net profit of Ambalal Sarabhai Enterprises Ltd changed from ₹ -4.87 crore to ₹ -0.27 crore over 8 quarters. This represents a CAGR of -76.45% The net profit of Ind-Swift Ltd changed from ₹ 2.36 crore to ₹ 256.6 crore over 8 quarters. This represents a CAGR of 942.73% .
  • The Dividend Payout of Ambalal Sarabhai Enterprises Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Ind-Swift Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ambalal Sarabhai Enterprises Ltd

  • Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses.
  • Each subsidiary is a distinct entity contributing its unique expertise and capabilities.
  • It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally.
  • ASE's strength is to lead with cutting edge technology by creating strategic technology tie-ups and collaborative partnerships through our broad national and international networks The Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments.
  • It operates in two segments, pharmaceuticals and electronics.

About Ind-Swift Ltd

  • Ind-Swift Limited (ISL) is an India-based pharmaceutical company.
  • The Company is engaged in the manufacturing and marketing of pharmaceutical finished dosage.
  • The products manufactured by the company include cephalosporins, quinolones, aminoglycosides, macrolides, chloramphenicol, tetracyclines, sulphonamides, antianaerobics and anti-fungals. The company manufactures various dosage forms, including oral solutions and suspensions; dry syrups and hard gelatin capsules; tablets; dermatologicals comprising creams, ointments, and gels; eye and ear drops; and injectables.
  • The company, through their different divisions, markets formulations focusing on the needs of various therapeutic segments, such as diabetology, cardiovascular, anesthesiology, oncology, ophthalmology, neuropsychiatry, gynecology, pediatric, ENT, surgery, internal medicine, dermatology, urology, cardiology, and dental specialty.

Ambalal Sarabhai Enterprises Ltd News Hub

News

Ambalal Sarabhai Enterprises schedules AGM

Ambalal Sarabhai Enterprises announced that the 47th Annual General Meeting(AGM) of the co...

Read more

07 Jun 2025 09:30

News

Ambalal Sarabhai Enterprises to table results

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

23 May 2025 17:45

News

Ambalal Sarabhai Enterprises to convene board meeting

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

06 Feb 2025 11:55

News

Ambalal Sarabhai Enterprises to convene board meeting

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

05 Nov 2024 13:38

News

Ambalal Sarabhai Enterprises announces board meeting date

Ambalal Sarabhai Enterprises will hold a meeting of the Board of Directors of the Company ...

Read more

03 Aug 2024 10:31

News

Ambalal Sarabhai Enterprises to conduct AGM

Ambalal Sarabhai Enterprises announced that the 46th Annual General Meeting (AGM) of the c...

Read more

29 May 2024 15:01

Ind-Swift Ltd News Hub

News

Ind-Swift Ltd leads gainers in 'B' group

Jayaswal Neco Industries Ltd, Aarti Drugs Ltd, Sampann Utpadan India Ltd and Soma Textiles...

Read more

15 Jul 2025 12:15

News

Ind-Swift to discuss results

Ind-Swift will hold a meeting of the Board of Directors of the Company on 25 June 2025. Po...

Read more

20 Jun 2025 10:07

News

Ind-Swift to convene board meeting

Ind-Swift will hold a meeting of the Board of Directors of the Company on 30 May 2025. Pow...

Read more

24 May 2025 17:38

News

Ind-Swift to conduct board meeting

Ind-Swift will hold a meeting of the Board of Directors of the Company on 11 February 2025...

Read more

07 Feb 2025 16:29

News

Ind-Swift EGM scheduled

Ind-Swift announced that an Extra Ordinary General Meeting (EGM) of the Company will be he...

Read more

21 Jan 2025 14:05

News

Ind-Swift to conduct board meeting

Ind-Swift will hold a meeting of the Board of Directors of the Company on 14 November 2024...

Read more

08 Nov 2024 16:42

SWOT Analysis Of Ind-Swift Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Ambalal Sarabhai Enterprises Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ind-Swift Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Ambalal Sarabhai Enterprises Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ambalal Sarabhai Enterprises Ltd and Ind-Swift Ltd

Which company has a larger market capitalization, Ambalal Sarabhai Enterprises Ltd or Ind-Swift Ltd?

Market cap of Ambalal Sarabhai Enterprises Ltd is 274 Cr while Market cap of Ind-Swift Ltd is 102 Cr

What are the key factors driving the stock performance of Ambalal Sarabhai Enterprises Ltd and Ind-Swift Ltd?

The stock performance of Ambalal Sarabhai Enterprises Ltd and Ind-Swift Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ambalal Sarabhai Enterprises Ltd and Ind-Swift Ltd?

As of July 16, 2025, the Ambalal Sarabhai Enterprises Ltd stock price is INR ₹35.82. On the other hand, Ind-Swift Ltd stock price is INR ₹18.92.

How do dividend payouts of Ambalal Sarabhai Enterprises Ltd and Ind-Swift Ltd compare?

To compare the dividend payouts of Ambalal Sarabhai Enterprises Ltd and Ind-Swift Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions